We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
Try the New Site
We're building a modernized ClinicalTrials.gov! Visit Beta.ClinicalTrials.gov to try the new functionality.
Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02981628
Brief Title: Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia
First Submitted : November 29, 2016
First Submitted that Met QC Criteria : November 30, 2016
First Posted : December 5, 2016 (Estimate)
Last Update Submitted that Met QC Criteria : May 20, 2023
Last Update Posted : May 23, 2023